Free Trial

Bellevue Healthcare (BBH) Competitors

Bellevue Healthcare logo
GBX 121.35 +0.55 (+0.46%)
As of 06:28 AM Eastern

BBH vs. TFG, FCSS, ASL, EDIN, GSS, FSV, JMG, BPCR, BBGI, and JPE

Should you be buying Bellevue Healthcare stock or one of its competitors? The main competitors of Bellevue Healthcare include Tetragon Financial (TFG), Fidelity China Special (FCSS), Aberforth Smaller Companies Trust (ASL), Edinburgh Investment (EDIN), Genesis Emerging Markets Fund (GSS), Fidelity Investment Trust - Fidelity Special Values (FSV), JPMorgan Emerging Markets (JMG), BioPharma Credit (BPCR), BBGI Global Infrastructure (BBGI), and JPMorgan Elect plc ­- Managed Growth (JPE). These companies are all part of the "asset management" industry.

Bellevue Healthcare vs.

Bellevue Healthcare (LON:BBH) and Tetragon Financial (LON:TFG) are both small-cap financial services companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.

Bellevue Healthcare received 87 more outperform votes than Tetragon Financial when rated by MarketBeat users. However, 77.42% of users gave Tetragon Financial an outperform vote while only 68.52% of users gave Bellevue Healthcare an outperform vote.

CompanyUnderperformOutperform
Bellevue HealthcareOutperform Votes
111
68.52%
Underperform Votes
51
31.48%
Tetragon FinancialOutperform Votes
24
77.42%
Underperform Votes
7
22.58%

Bellevue Healthcare has a net margin of 169.10% compared to Tetragon Financial's net margin of 57.23%. Tetragon Financial's return on equity of 4.68% beat Bellevue Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Bellevue Healthcare169.10% -4.48% N/A
Tetragon Financial 57.23%4.68%3.14%

40.6% of Bellevue Healthcare shares are held by institutional investors. Comparatively, 3.2% of Tetragon Financial shares are held by institutional investors. 0.1% of Bellevue Healthcare shares are held by insiders. Comparatively, 17.8% of Tetragon Financial shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Bellevue Healthcare pays an annual dividend of GBX 6 per share and has a dividend yield of 5.0%. Tetragon Financial pays an annual dividend of GBX 44 per share and has a dividend yield of 313.4%. Bellevue Healthcare pays out -91.3% of its earnings in the form of a dividend. Tetragon Financial pays out 2,822.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Tetragon Financial has higher revenue and earnings than Bellevue Healthcare. Bellevue Healthcare is trading at a lower price-to-earnings ratio than Tetragon Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bellevue Healthcare-£9.60M-31.03-£16.23M-£6.57-18.37
Tetragon Financial£22.12B0.05£12.66B£1.569.01

In the previous week, Tetragon Financial had 2 more articles in the media than Bellevue Healthcare. MarketBeat recorded 2 mentions for Tetragon Financial and 0 mentions for Bellevue Healthcare. Bellevue Healthcare's average media sentiment score of 0.00 beat Tetragon Financial's score of -0.05 indicating that Bellevue Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Bellevue Healthcare Neutral
Tetragon Financial Neutral

Summary

Tetragon Financial beats Bellevue Healthcare on 11 of the 16 factors compared between the two stocks.

Get Bellevue Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for BBH and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BBH vs. The Competition

MetricBellevue HealthcareAsset Management IndustryFinancial SectorLON Exchange
Market Cap£297.72M£1.15B£3.84B£2.56B
Dividend Yield3.82%4.46%4.21%4.97%
P/E Ratio-18.3721.8113.05132.50
Price / Sales-31.032,287.401,692.12227,865.53
Price / CashN/A61.4750.4928.11
Price / Book0.811.143.414.54
Net Income-£16.23M£262.88M£1.25B£5.84B
7 Day PerformanceN/A1.51%1.37%3.31%
1 Month Performance-1.90%10.16%12.85%9.43%
1 Year Performance-15.05%2.80%12.94%114.47%

Bellevue Healthcare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BBH
Bellevue Healthcare
N/AGBX 121.35
+0.5%
N/A-15.0%£299.08M£-9,595,061.74-18.46N/A
TFG
Tetragon Financial
N/AGBX 14
-0.4%
N/A+43.6%£1.14B£22.12B8.98N/A
FCSS
Fidelity China Special
N/AGBX 227.50
+2.0%
N/A+8.2%£1.13B£-177,570,734.591.13N/A
ASL
Aberforth Smaller Companies Trust
N/AGBX 1,322
+0.2%
N/A-3.9%£1.10B£226.05M4.34N/APositive News
EDIN
Edinburgh Investment
N/AGBX 751
+0.9%
N/A+6.4%£1.09B£189.32M6.01N/A
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626Gap Down
FSV
Fidelity Investment Trust - Fidelity Special Values
N/AGBX 324.50
flat
N/A+13.1%£1.05B£237.18M4.7225,000Earnings Report
Positive News
JMG
JPMorgan Emerging Markets
N/AGBX 99.40
+0.7%
N/A+0.4%£1.05B£97.45M13.17N/APositive News
BPCR
BioPharma Credit
N/AGBX 0.86
+0.5%
N/A-3.2%£1.02B£12.99B9.78N/ANews Coverage
BBGI
BBGI Global Infrastructure
N/AGBX 141.90
+0.6%
N/A+6.4%£1.01B£67.98M18.371,160
JPE
JPMorgan Elect plc ­- Managed Growth
N/AN/AN/AN/A£1.00B£104.78M1,250.00N/A

Related Companies and Tools


This page (LON:BBH) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners